- Home
- MGPI vs XNCR Comparison
MGPI vs XNCR Comparison
Compare MGPI & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGPI
- XNCR
- Stock Information
- Founded
- MGPI 1941
- XNCR 1997
- Country
- MGPI United States
- XNCR United States
- Employees
- MGPI N/A
- XNCR N/A
- Industry
- MGPI Beverages (Production/Distribution)
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- MGPI Consumer Staples
- XNCR Health Care
- Exchange
- MGPI Nasdaq
- XNCR Nasdaq
- Market Cap
- MGPI 604.8M
- XNCR 579.3M
- IPO Year
- MGPI 1988
- XNCR 2013
- Fundamental
- Price
- MGPI $29.58
- XNCR $9.14
- Analyst Decision
- MGPI Strong Buy
- XNCR Buy
- Analyst Count
- MGPI 5
- XNCR 8
- Target Price
- MGPI $45.40
- XNCR $29.29
- AVG Volume (30 Days)
- MGPI 379.5K
- XNCR 1.1M
- Earning Date
- MGPI 05-01-2025
- XNCR 05-07-2025
- Dividend Yield
- MGPI 1.63%
- XNCR N/A
- EPS Growth
- MGPI N/A
- XNCR N/A
- EPS
- MGPI 0.50
- XNCR N/A
- Revenue
- MGPI $654,715,000.00
- XNCR $127,228,000.00
- Revenue This Year
- MGPI N/A
- XNCR N/A
- Revenue Next Year
- MGPI N/A
- XNCR $27.37
- P/E Ratio
- MGPI $58.92
- XNCR N/A
- Revenue Growth
- MGPI N/A
- XNCR N/A
- 52 Week Low
- MGPI $25.12
- XNCR $7.16
- 52 Week High
- MGPI $92.52
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- MGPI 41.04
- XNCR 54.61
- Support Level
- MGPI $28.72
- XNCR $7.34
- Resistance Level
- MGPI $31.36
- XNCR $7.99
- Average True Range (ATR)
- MGPI 0.94
- XNCR 0.49
- MACD
- MGPI -0.38
- XNCR 0.19
- Stochastic Oscillator
- MGPI 19.07
- XNCR 90.82
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.